Paper41952002
Computational framework to quantify synergistic ligand activity in insulin secretion and resistance pathways in type 2 diabetes.
Zhou J and 3 others. J Comput Aided Mol Des, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Computational framework to quantify synergistic ligand activity in insulin secretion and resistance pathways in type 2 diabetes. Papers, record 41952002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41952002
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Computational framework to quantify synergistic ligand activity in insulin secretion and resistance pathways in type 2 diabetes.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Insulin Resistance | Major topic |
| Insulin Secretion | Major topic |
| Insulin | Major topic |
| Hypoglycemic Agents | Major topic |
| Humans | |
| Ligands | |
| Kinesins | |
| Receptor, Insulin | |
| Glucagon-Like Peptide-1 Receptor | |
| PPAR gamma | |
| Molecular Docking Simulation | |
| Receptor, IGF Type 1 | |
| Receptor, Fibroblast Growth Factor, Type 1 | |
| Antigens, CD |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RS-2023-00208567 | the National Research Foundation of Korea | PubMed |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39657879 | MDbDMRP: A novel molecular descriptor-based computational model to identify drug-miRNA relationships. | Int J Biol Macromol | 2025 | https://conductscience.org/library/papers/39657879 | PubMed |
| 2 | 36618987 | PathIN: an integrated tool for the visualization of pathway interaction networks. | Comput Struct Biotechnol J | 2023 | https://conductscience.org/library/papers/36618987 | PubMed |
| 3 | 41008970 | Elucidating Key Components and Mechanisms Underlying the Synergistic Anti-Type 2 Diabetes Effect of Morus alba L. and Siraitia grosvenorii Combination: An Integrated In Vitro Enzymology, Untargeted Metabolomics, and Network Pharmacology Approach. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/41008970 | PubMed |
| 4 | 39261471 | Automated design of multi-target ligands by generative deep learning. | Nat Commun | 2024 | https://conductscience.org/library/papers/39261471 | PubMed |
| 5 | 39694914 | Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes. | Diabetologia | 2025 | https://conductscience.org/library/papers/39694914 | PubMed |
| 6 | 41373598 | Deep Generative AI for Multi-Target Therapeutic Design: Toward Self-Improving Drug Discovery Framework. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373598 | PubMed |
| 7 | 37035220 | Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress. | World J Diabetes | 2023 | https://conductscience.org/library/papers/37035220 | PubMed |
| 8 | 31610891 | You Cannot Have Your Synergy and Efficacy Too. | Trends Pharmacol Sci | 2019 | https://conductscience.org/library/papers/31610891 | PubMed |
| 9 | 26522682 | Vitamin D deficiency impairs glucose-stimulated insulin secretion and increases insulin resistance by reducing PPAR-γ expression in nonobese Type 2 diabetic rats. | J Nutr Biochem | 2016 | https://conductscience.org/library/papers/26522682 | PubMed |
| 10 | 39289339 | Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39289339 | PubMed |
| 11 | 35401680 | Integrative Pathway Analysis of SNP and Metabolite Data Using a Hierarchical Structural Component Model. | Front Genet | 2022 | https://conductscience.org/library/papers/35401680 | PubMed |
| 12 | 28328746 | Cross-Talk Between Insulin Signaling and G Protein-Coupled Receptors. | J Cardiovasc Pharmacol | 2017 | https://conductscience.org/library/papers/28328746 | PubMed |
| 13 | 41399804 | Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort study. | Lancet Reg Health Eur | 2026 | https://conductscience.org/library/papers/41399804 | PubMed |
| 14 | 38496986 | (Re-)Viewing Role of Intracellular Glucose Beyond Extracellular Regulation of Glucose-Stimulated Insulin Secretion by Pancreatic Cells. | ACS Omega | 2024 | https://conductscience.org/library/papers/38496986 | PubMed |
| 15 | 37701904 | Comparison of the efficacy and safety of 10 glucagon-like peptide-1 receptor agonists as add-on to metformin in patients with type 2 diabetes: a systematic review. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37701904 | PubMed |
| 16 | 38843874 | Systematic Investigation of Dual-Target-Directed Ligands. | J Med Chem | 2024 | https://conductscience.org/library/papers/38843874 | PubMed |
| 17 | 38317535 | Identification of potent BRD4-BD1 inhibitors using classical and steered molecular dynamics based free energy analysis. | J Cell Biochem | 2024 | https://conductscience.org/library/papers/38317535 | PubMed |
| 18 | 36512705 | Cytoscape stringApp 2.0: Analysis and Visualization of Heterogeneous Biological Networks. | J Proteome Res | 2023 | https://conductscience.org/library/papers/36512705 | PubMed |
| 19 | 28379339 | SynergyFinder: a web application for analyzing drug combination dose-response matrix data. | Bioinformatics | 2017 | https://conductscience.org/library/papers/28379339 | PubMed |
| 20 | 39353925 | Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39353925 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41952002
GET https://conductscience.org/api/papers/v1/41952002/references?page=2